학술논문
A phase II randomised controlled trial of adjuvant tumour-infiltrating lymphocytes for pretreatment Epstein-Barr virus DNA-selected high-risk nasopharyngeal carcinoma patients
Document Type
Article
Author
Source
In European Journal of Cancer September 2023 191
Subject
Language
ISSN
0959-8049